On 12 Nov 2026 our base value for Cooper Companies (The) is $51.28 a share, 17.5% below its $62.19 close; 0 of 1 valuation methods put it above the price.
| Method | Value | vs price | Basis |
|---|---|---|---|
| Discounted cash flow | $51.28 | -17.5% | free cash flow $678.00m, growth 0.6% for 5 years, then fading to 3% over 5 more, discounted at 9.09%; stress floor $38.26 |
| Exit multiple (P/E) | — | — | no exit multiple: the five-year median of 26.8x is 2.0x the 13.2x this name trades at today (limit 1.5x) — the market has re-rated the name, so its own history prices a business it is no longer paid for. The forward PE is not a substitute: it is today's price divided by earnings, and an anchor built from it can only restate the price |
| Sum of the parts | — | — | no sum of the parts: this run holds no segment disclosure for the name |
| Price to sales | — | — | not reached: the cash-flow or earnings methods produced an anchor, so this fallback was not run |
| Tangible book | — | — | used only for lenders, where book value is the business |
| Price to FFO (REITs) | — | — | used only for REITs |
Each working is rebuilt by code from the valuation's own figures and checked against the published value.
The discount rate:
| Risk-free rate | 5.13% (10-year US Treasury yield) |
| Company's own beta | 0.83 (5 years of monthly returns against the S&P 500; standard error 0.22) |
| Peer beta | 0.77 (median of 58 S&P 500 Health Care companies) |
| Blend of own and peers | 0.82 (80% own, 20% peers, weighted by how precisely the company's own beta is measured) |
| Adjusted beta | 0.88 (0.67 × 0.82 + 0.33, pulled toward the market's 1.0) |
| Equity risk premium | 4.5% |
| Discount rate = risk-free + adjusted beta × premium | 9.09% |
Free cash flow grows 0.60% a year for 5 years, then fades in equal steps toward 3% over 5 more; each year is discounted by 1 ÷ (1 + rate)^year:
| Year | Growth | Free cash flow | Discount factor | Present value |
|---|---|---|---|---|
| Now | — | $678.00m | — | — |
| Year 1 | 0.60% | $682.07m | 0.9167 | $625.23m |
| Year 2 | 0.60% | $686.16m | 0.8403 | $576.57m |
| Year 3 | 0.60% | $690.28m | 0.7703 | $531.70m |
| Year 4 | 0.60% | $694.42m | 0.7061 | $490.32m |
| Year 5 | 0.60% | $698.59m | 0.6473 | $452.16m |
| Year 6 | 1.00% | $705.57m | 0.5933 | $418.63m |
| Year 7 | 1.40% | $715.45m | 0.5439 | $389.12m |
| Year 8 | 1.80% | $728.33m | 0.4986 | $363.12m |
| Year 9 | 2.20% | $744.35m | 0.4570 | $340.18m |
| Year 10 | 2.60% | $763.70m | 0.4189 | $319.95m |
| Terminal value = year-10 cash flow × (1 + 3%) ÷ (9.09% − 3%) | $12.92bn |
| Terminal value in today's money | $5.41bn |
| Present value of years 1–10 | $4.51bn |
| Total present value | $9.92bn |
| Shares outstanding | 193.40m |
| Value per share = total ÷ shares | $51.28 |
How the DCF value moves with the discount rate and the starting growth (the middle cell is the published value):
| Discount rate | Growth -4.4% | Growth 0.6% | Growth 5.6% |
|---|---|---|---|
| 8.09% | $44.63 | $61.09 | $83.32 |
| 9.09% | $37.85 | $51.28 | $69.33 |
| 10.09% | $32.96 | $44.23 | $59.30 |
The same DCF at each beta, starting growth unchanged:
| Beta | Value | Discount rate | DCF value |
|---|---|---|---|
| Company's own beta | 0.83 | 8.87% | $53.20 |
| Peer beta | 0.77 | 8.59% | $55.70 |
| Adjusted beta (used) | 0.88 | 9.09% | $51.28 |
The base value is the average of the methods kept in it:
| Method | Value |
|---|---|
| Discounted cash flow | $51.28 |
One method is kept, so the base value is its value: $51.28
Base value $51.28 a share
One-year price simulation: a 10% chance the price is below $34.65 and a 10% chance it is above $109.01 in a year; a 49% chance it is higher than today's $62.19, from 44.49% volatility. The simulation assumes the price drifts up at our discount rate of 9.09% a year.
At $62.19 the price implies free cash flow growing 3.8% a year for five years and then fading toward 3% over five more; its revenue has grown 0.6%.
| Week | Price | Base value |
|---|---|---|
| 2 Oct 2026 | $56.91 | $51.15 |
| 9 Oct 2026 | $54.37 | $51.51 |
| 16 Oct 2026 | $57.94 | $52.03 |
| 23 Oct 2026 | $61.21 | $52.75 |
| 30 Oct 2026 | $59.55 | $52.94 |
| 6 Nov 2026 | $62.36 | $53.54 |
| 12 Nov 2026 | $62.19 | $51.28 |
Data as of 12 Nov 2026; financials to 31 Jul 2026. Sources: company filings via EODHD, SEC EDGAR, US Treasury. How these values are computed. Not investment advice.
Run a full Desk Run on COO · Cooper Companies (The) company page · Call and put prices